The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
NCT06365541
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
Interventions
DRUG:
Dapagliflozin
Sponsor
The People's Hospital of Gaozhou